Literature DB >> 5658325

Fate and metabolism of some hallucinogenic indolealkylamines.

U Ahlborg, B Holmstedt, J E Lindgren.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5658325     DOI: 10.1016/s1054-3589(08)60320-8

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN: 0568-0123


× No keyword cloud information.
  5 in total

1.  Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor.

Authors:  Adam L Halberstadt; David E Nichols; Mark A Geyer
Journal:  Psychopharmacology (Berl)       Date:  2012-01-06       Impact factor: 4.530

2.  Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor.

Authors:  D G Grahame-Smith
Journal:  Br J Pharmacol       Date:  1971-12       Impact factor: 8.739

3.  Carbon 11 labeling of the psychoactive drug o-methyl-bufotenine and its distribution in the animal organism.

Authors:  G Berger; M Mazière; C Marazano; D Comar
Journal:  Eur J Nucl Med       Date:  1978-04-01

4.  Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.

Authors:  Adam L Halberstadt; Mahalah R Buell; Virginia L Masten; Victoria B Risbrough; Mark A Geyer
Journal:  Psychopharmacology (Berl)       Date:  2008-07-08       Impact factor: 4.530

Review 5.  A narrative synthesis of research with 5-MeO-DMT.

Authors:  Anna O Ermakova; Fiona Dunbar; James Rucker; Matthew W Johnson
Journal:  J Psychopharmacol       Date:  2021-10-19       Impact factor: 4.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.